Aridis Pharmaceuticals Inc. (ARDS) Social Stream
Aridis Pharmaceuticals Inc (ARDS) Price Targets From Analysts
Use the tables below to see what analysts covering Aridis Pharmaceuticals Inc think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-09-02 | 4 | $22 | $13 | $18 | $1.7 | 958.82% |
| 2021-11-11 | 4 | $19 | $10 | $15 | $1.7 | 782.35% |
| 2022-01-27 | 2 | $19 | $10 | $14 | $1.7 | 723.53% |
The Trend in the Analyst Price Target
ARDS's average price target has moved down $4.6 over the prior 21 months.
Over the past 42 weeks, ARDS's average upside potential has been 300.34%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-07-03 | 5 | 22 | 11 | 17 | 7.489 | 127% |
| 2021-07-10 | 5 | 22 | 11 | 17 | 7.205 | 135.95% |
| 2021-08-01 | 5 | 22 | 17 | 19 | 4.990 | 280.76% |
| 2021-09-19 | 4 | 22 | 13 | 18 | 4.020 | 347.76% |
| 2022-01-27 | 2 | 19 | 10 | 14 | 2.010 | 596.52% |
ARDS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 2 | 0 | 0 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
ARDS's average broker recommendation rating improved by 1 over the prior 92 days.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, Aridis Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is greater than 392.82% of them.
- To contextualize these metrics, consider that out of all US stocks, Aridis Pharmaceuticals Inc's number of analysts covering the stock is higher than 54.01% of them.
- In terms of how Aridis Pharmaceuticals Inc fares relative to stocks in the micro market cap category, note that its variance in analysts' estimates is lower than -202.67% of that group.
- To contextualize these metrics, consider that out of Healthcare stocks, Aridis Pharmaceuticals Inc's average analyst price target is greater than 101.3% of them.
Stocks similar to Aridis Pharmaceuticals Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are APVO, ANEB, and ALRN.
Make investment decisions regarding ARDS using the data that counts. Try POWR Ratings for free.